LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹93 Cr | ₹63 Cr | ₹39 Cr | ₹76 Cr | ₹69 Cr |
What is the latest Cash Flow from Operating Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹63 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹69 Cr |
How is Cash Flow from Operating Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹93 Cr | 47.14 | |
| Mar2024 | ₹63 Cr | 61.01 | |
| Mar2023 | ₹39 Cr | -48.43 | |
| Mar2022 | ₹76 Cr | 9.91 | |
| Mar2021 | ₹69 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,247.8 Cr | 2.8% | -1.3% | 12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.8% |
-1.3% |
12.3% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses